Healthcare - Biotechnology - NASDAQ - US
$ 0.007
0 %
$ 34.1 K
Market Cap
0.0
P/E
INCOME STATEMENT
0
REVENUE
-42.1 M
OPERATING INCOME
-39.6 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Calithera Biosciences, Inc.
| Revenue | 0 |
| Cost Of Revenue | 1.38 M |
| Gross Profit | -1.38 M |
| Operating Expenses | 40.7 M |
| Operating Income | -42.1 M |
| Other Expenses | -2.42 M |
| Net Income | -39.6 M |
Income Statement
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Revenue | 0 | 9.8 | 0 | 0 | 22.3 | 26.0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||||
| Cost Of Revenue | 1.4 | 1.4 | 1.9 | 1.8 | 0 | 0 | 0.3 | 0 | 0 | 0 | 0 |
| Gross Profit | (1.4) | 8.3 | (1.9) | (1.8) | 22.3 | 26.0 | (0.3) | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||||||||
| Operating Expenses | 40.7 | 74.3 | 91.4 | 92.9 | 79.5 | 55.6 | 38.3 | 32.8 | 21.7 | 12.4 | 8.0 |
| Selling, General and Administrative Expenses | 12.2 | 20.9 | 20.4 | 16.6 | 13.3 | 12.5 | 10.6 | 9.1 | 5.4 | 2.5 | 1.4 |
| Research and Development Expenses | 28.5 | 53.5 | 71.0 | 76.3 | 66.2 | 43.1 | 27.7 | 23.7 | 16.4 | 9.9 | 6.6 |
| Operating Income | (42.1) | (115.4) | (91.4) | (92.9) | (57.3) | (29.7) | (38.3) | (32.8) | (21.7) | (12.4) | (8.0) |
| PRE-TAX INCOME | |||||||||||
| Interest Income Expense | (20.8) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 2.4 | 0.3 | 1.2 | 3.0 | 2.7 | 1.9 | 0.3 | 0.2 | 9 K | 1 K | 0 |
| Pre-Tax Income | (39.6) | (115.1) | (90.1) | (89.9) | (54.6) | (27.8) | (38.0) | (32.6) | (21.7) | (12.4) | (8.0) |
| NET INCOME | |||||||||||
| Tax Provision | (20.8) | 50.2 | (1.6) | (3.5) | (3.2) | (0.4) | (0.3) | (0.4) | (0.4) | 0 | 0 |
| Net Income | (18.9) | (165.3) | (88.5) | (86.3) | (51.5) | (27.8) | (38.0) | (32.6) | (21.7) | (12.4) | (8.0) |
| EPS | 7.94 | 44.8 | 25.7 | 36.5 | 28.1 | 16.9 | 39 | 36.2 | 93.3 | 31.4 | 20.2 |